Clinical Trial Update: Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating azacitidine plus entinostat before chemotherapy in patients with advanced non-small cell lung cancer. The trial was terminated and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Entinostat (entinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-27